Criteria for diagnosis of HIV-1 associated dementia complex: Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41:778-784, 1991.
Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics. Alcohol and Alcoholism 33(2):151-156, 1998.
Lesbians in the medical setting. In: Cabaj, R.P., and Stein, T.S., eds. Homosexuality and Mental Health: A Comprehensive Review. Washington, DC: American Psychiatric Press, 1996. pp. 659-671.
Medical Management of HIV Infection. Baltimore, MD: Johns Hopkins AIDS Service, 1999. http://www.hopkins-aids.edu/publications/index_pub.html [Accessed August 4, 1999].
Standards of Care: Client Assessment and Treatment Protocol. Unpublished tool used by the Opiate Treatment Outpatient Program, San Francisco General Hospital, University of California at San Francisco, 1999.
Drug abuse treatment for HIV-infected patients. In: Sorensen, J.L.; Wermuth, L.A.; Gibson, D.R.; Choi, K.-H., Guydish, J.R.; and Batki, S.L., eds. Preventing AIDS in Drug Abusers and Their Sexual Partners. New York: Guilford Press, 1991. pp. 77-98.
The influence of alcohol drinking and alcohol use disorders on psychiatric disorders and suicidal behavior. Alcoholism, Clinical and Experimental Research 22(7 Suppl):333S-345S, 1998.
The relationship of mean daily blood alcohol levels to admission MAST, clinic absenteeism, and depression in alcoholic methadone patients. Drug and Alcohol Dependence 32:113-118, 1993.
Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug abusers. Journal of Acquired Immune Deficiency Syndromes 7(10):1040-1049, 1994.
Immune function and neuropsychological performance in HIV-1-infected homosexual men. Journal of Acquired Immune Deficiency Syndromes 6(6):592-601, 1993a.
Case management: An alternative approach to working with intravenous drug abusers. In: Ashery, R.S., ed. Progress and Issues in Case Management. NIDA Research Monograph Series, Number 127. DHHS Pub. No. (ADM) 92-1946. Rockville, MD: National Institute on Drug Abuse, 1992. pp. 92-111.
Effectiveness of reducing needle-related risks for HIV through indigenous outreach to injection drug users. American Journal on Addictions 1(4):277-287, 1992.
AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers. Journal of Acquired Immune Deficiency Syndromes 1(4):412-413, 1988.
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 332(11):693-699, 1995.
Suicide risk and pain in cancer and AIDS patients. In: Chapman, C.R., and Foley, K.M., eds. Current and Emerging Issues in Cancer Pain: Research and Practice. New York: Raven Press, 1993. pp. 49-65.
Pain in the ambulatory AIDS patient: Prevalence and psychosocial correlates. Proceedings of the 38th Annual Meeting, Academy of Psychosomatic Medicine, Atlanta, GA, October 17-20, 1991.
HIV-associated dementia: A clinician's guide to early detection, diagnosis, and intervention. Families in Society: The Journal of Contemporary Human Services 75(6):333-345, 1994.
Participation in an outreach-based coupon distribution program for free methadone detoxification. Hospital and Community Psychiatry 44(11):1066-1072, 1993.
Substance abuse in gay men, lesbians, and bisexual individuals. In: Cabaj, R.P., and Stein, T.S., eds. Textbook of Homosexuality and Mental Health. Washington, DC: American Psychiatric Press, 1996. pp. 783-799.
What percentage of the California correctional population has a history of substance abuse? California Correctional Statistics, CCS 1-98, July 1998. http://www.cdc.state.ca.us/reports/offender.htm [Accessed July 12, 1998].
Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. American Journal of Public Health 82:573-575, 1992.
Ongoing high-risk sexual behaviors in relation to recreational drug use in sexual encounters. Analysis of 5 years of data from the Toronto Sexual Contact Study. Annals of Epidemiology 3(3):272-280, 1993.
"Prolongation of life and prevention of AIDS complications in advanced HIV immunodeficiency with ritonavir." Eleventh International Conference on AIDS, Vancouver, Canada, July 7-12, 1996.
Psychological and behavioral impact among intravenous drug abusers of learning HIV test results. International Journal of the Addictions 25:409-426, 1990.
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. Morbidity and Mortality Weekly Report 41, December 18, 1992. http://www.cdc.gov/mmwr [Accessed August 20, 1999].
Assessment and Treatment of Patients With Coexisting Mental Illness and Alcohol and Other Drug Abuse. Treatment Improvement Protocol (TIP) Series, Number 9. DHHS Pub. No. (SMA) 94-2078. Washington, DC: U.S. Government Printing Office, 1994a.
Treatment for Alcohol and Other Drug Abuse: Opportunities for Collaboration. Technical Assistance Publication (TAP) Series, Number 11. DHHS Pub. No. (SMA) 94-2075. Washington, DC: U.S. Government Printing Office, 1994b.
Developing State Outcomes Monitoring Systems for Alcohol and Other Drug Abuse Treatment. Treatment Improvement Protocol (TIP) Series, Number 14. DHHS Pub. No. (SMA) 95-3031. Washington, DC: U.S. Government Printing Office, 1995a.
Treatment for HIV-Infected Alcohol and Other Drug Abusers. Treatment Improvement Protocol (TIP) Series, Number 15. DHHS Pub. No. (SMA) 95-3038. Washington, DC: U.S. Government Printing Office, 1995b.
Planning for Alcohol and Other Drug Abuse Treatment for Adults in the Criminal Justice System. Treatment Improvement Protocol (TIP) Series, Number 17. DHHS Pub. No. (SMA) 95-3039. Washington, DC: U.S. Government Printing Office, 1995c.
The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Abuse Treatment Providers. Treatment Improvement Protocol (TIP) Series, Number 18. DHHS Pub. No. (SMA) 95-3047. Washington, DC: U.S. Government Printing Office, 1995d.
Detoxification From Alcohol and Other Drugs. Treatment Improvement Protocol (TIP) Series, Number 19. DHHS Pub. No. (SMA) 95-3046. Washington, DC: U.S. Government Printing Office, 1995e.
LAAM in the Treatment of Opiate Addiction. Treatment Improvement Protocol (TIP) Series, Number 22. DHHS Pub. No. (SMA) 95-3052. Washington, DC: U.S. Government Printing Office, 1995g.
Treatment Drug Courts: Integrating Substance Abuse Treatment With Legal Case Processing. Treatment Improvement Protocol (TIP) Series, Number 23. DHHS Pub. No. (SMA) 96-3113. Washington, DC: U.S. Government Printing Office, 1996.
A Guide to Substance Abuse Services for Primary Care Clinicians. Treatment Improvement Protocol (TIP) Series, Number 24. DHHS Pub. No. (SMA) 97-3139. Washington, DC: U.S. Government Printing Office, 1997.
Substance Use Disorder Treatment for People With Physical and Cognitive Disabilities. Treatment Improvement Protocol (TIP) Series, Number 29. DHHS Pub. No. (SMA) 98-3249. Washington, DC: U.S. Government Printing Office, 1998c.
Continuity of Offender Treatment for Substance Use Disorders From Institution to Community. Treatment Improvement Protocol (TIP) Series, Number 30. DHHS Pub. No. (SMA) 98-3245. Washington, DC: U.S. Government Printing Office, 1998d.
Screening and Assessing Adolescents for Substance Use Disorders. Treatment Improvement Protocol (TIP) Series, Number 31. DHHS Pub. No. (SMA) 99-3282. Washington, DC: U.S. Government Printing Office, 1999a.
Treatment of Adolescents With Substance Use Disorders. Treatment Improvement Protocol (TIP) Series, Number 32. DHHS Pub. No. (SMA) 99-3283. Washington, DC: U.S. Government Printing Office, 1999b.
Substance Abuse Treatment for Persons With Child Abuse and Neglect Issues. Treatment Improvement Protocol (TIP) Series, Number 36. DHHS Pub. No. (SMA) 00-3357. Washington, DC: U.S. Government Printing Office, 2000.
Integrating Substance Abuse Treatment and Vocational Services. Treatment Improvement Protocol (TIP) Series, Number 38. Washington, DC: U.S. Government Printing Office, in press (a).
Gay, Lesbian, Bisexual, and Transgender Populations. Technical Assistance Publication (TAP) Series. Washington, DC: U.S. Government Printing Office, in press (b).
Unexplained immunodeficiency and opportunistic infections in infants--New York, New Jersey, California. Morbidity and Mortality Weekly Report 31(49):665-667, 1982.
Update: Reducing HIV transmission in intravenous-drug users not in drug treatment in the United States. Morbidity and Mortality Weekly Report 39(31):529, 536-538, 1990.
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. Morbidity and Mortality Weekly Report 41(51):961-962, 1992.
Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. Morbidity and Mortality Weekly Report 43(RR-11):1-20, 1994.
U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. Morbidity and Mortality Weekly Report 44(RR-7):1-15, 1995.
HIV/AIDS education and prevention programs for adults in prisons and jails and juveniles in confinement facilities--United States, 1994. Morbidity and Mortality Weekly Report 45(13):268-271, 1996a.
Provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV. Morbidity and Mortality Weekly Report 45(22):468-472, 1996c.
1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary. Morbidity and Mortality Weekly Report 46(RR-12):1-45, 1997a.
Assessing Health Risk Behaviors Among Young People: Youth Risk Behavior Surveillance System, 1998b. http://www.cdc.gov/nccdphp/dash/yrbs/yrbs98.pdf [Accessed May 10, 1999].
Basic Statistics--Ten States/Territories and Cities Reporting Highest Number of AIDS Cases. 1998c. http://www.cdc.gov/ nchstp/hiv_aids/stats/topten.htm [Accessed March 18, 1999].
Public health service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weekly Report 47(RR-7):1-28, 1998g.
Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Morbidity and Mortality Weekly Report 47(RR-2):1-30, 1998h.
Preventing occupational HIV transmission to health care workers. 1999d. http://www.cdc.gov/nchstp/hiv_aids/pubs/facts/hcw.htm [Accessed January 10, 2000].
Young people at risk--epidemic shifts further toward young women and minorities. 1999e. http://www.cdc.gov/nchstp/hiv_aids/pubs/facts/youth.htm[Accessed January 10, 2000].
Births and deaths: Preliminary data for 1998. National Vital Statistics Reports 47(25), 1999f. http://www.cdc.gov/nchs/data/nvs47_25.pdf [Accessed April 4, 2000].
Risk assessment to improve targeting of HIV counseling and testing services for STD clinic patients. Sexually Transmitted Diseases 25(10):539-543, 1998.
Reliability of anergy skin-testing in persons with HIV infection. American Journal of Respiratory and Critical Care Medicine 153(6 pt. 1):1982-1984, 1996.
A risk profile of street youth in northern California: Implications for gender-specific human immunodeficiency virus prevention. Journal of Adolescent Health 20(5):343-353, 1997.
Relation between psychiatric syndromes and behaviorally defined sexual orientation in a sample of the U.S. population. American Journal of Epidemiology 151(5):516-523, 2000.
Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 349:1868-1873, 1997.
Reduction in sexual risk behaviors among HIV seropositve drug abusers in Puerto Rico. International Conference on AIDS 11(2):146 (Abstract No. We.C. 3512) 1996.
Systems alliance and support (SAS): A program of intensive case management for chronic public inebriates. Alcohol Treatment Quarterly 10(3/4):125-138, 1993.
The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. Archives of General Psychiatry 54:1130-1135, 1997.
Towards a Culturally Competent System of Care: A Monograph on Effective Services for Minority Children Who Are Severely Emotionally Disturbed. Washington, DC: Child and Adolescent Service System Program, Technical Assistance Center, Georgetown University Child Development Center, 1989.
Incidence and predictors of virologic failure of indinavir and/or ritonavir in an urban health clinic.Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Abstract No. LB-02. Toronto, Canada, September 28-October 1, 1997.
Notes on the management of difference. In: Stein, T.S., and Cohen, C.C., eds. Contemporary Perspectives on Psychotherapy With Lesbians and Gay Men. New York: Plenum Press, 1986.
Differences by ancestry in sociodemographics and risk behaviors among Hispanics with AIDS. The Supplement to HIV and AIDS Surveillance Project Group. Ethnicity and Disease 7(3):200-206, 1997.
Advances in the pathophysiology and treatment of HIV-associated wasting. Improving the Management of HIV Disease 4(5), 1997. http://hivinsite.ucsf.edu/medical/iasusa/2098.2e2e.html [Accessed March 9, 2000].
Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial. Lancet 353(9158):1035-1039, 1999.
Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Archives of Internal Medicine 158:2257(2264, 1998.
HIV infection: From dual to triple diagnosis. In: Kranzler, H.R., and Rounsaville, B.J., eds. Dual Diagnosis and Treatment. New York: Marcel Dekker, 1998. pp. 503-534.
Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease. American Journal of Drug and Alcohol Abuse 22(4): 475-487, 1996.
The accelerated intake: A method for increasing initial attendance to outpatient cocaine treatment. Journal of Applied Behavior Analysis 29:387-389, 1996.
IL-2 plus HAART sharply reduces HIV in hiding places. UniSci Science and Research News, November 16, 1998. http://unisci.com/stories/19984/1116983.htm [Accessed April 15, 1999].
"Mini Mental State": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12:196-198, 1975.
Initial assessment of patients infected with human immunodeficiency virus: The yield and cost of laboratory testing. Journal of AIDS 7:1134(1140, 1994.
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. American Journal of Epidemiology 142:864-874, 1995.
Use of buprenorphine in the treatment of opioid addiction, II: Physiologic and behavioral effects of daily and alternate day administration and abrupt withdrawal. Clinical Pharmacology and Therapeutics 47:525-534, 1990.
Naming names: Will the squabble over HIV reporting tear us apart? POZ March 1999. http://www.thebody.com/poz/columns/3_99/policy.html [Accessed April 15, 1999].
Use of preventive interventions by persons infected with type-1 human immunodeficiency virus (HIV-1). The Pulmonary Complications of HIV Study Group. American Journal of Preventive Medicine 10(5):259-266, 1994.
Qualitative research considerations and other issues in the study of methamphetamine use among men who have sex with other men. In: Lambert, E.Y.; Ashery, R.S.; and Needle, R.H., eds. Qualitative Methods in Drug Abuse and HIV Research. NIDA Research Monograph Series, Number 157. NIDA Pub. No. 95-4025. Rockville, MD: National Institute on Drug Abuse, 1995. pp. 156-181.
Continuity of care in addictions treatment: The role of advocacy and coordination in case management. American Journal of Drug and Alcohol Abuse 21(4):433-451, 1995.
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. New England Journal of Medicine 335:1081-1090, 1996.
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.. New England Journal of Medicine 327:1842-1848, 1992.
HIV prevalence and risk behavior among injecting drug abusers who participate in "low threshold" methadone programs in Amsterdam. American Journal of Public Health 82:547-551, 1992.
Burnout and AIDS care-related factors in HIV community clinical nurse specialists in the North of England. Journal of Advanced Nursing 29(4):984-993, 1999.
"Adherence and effectiveness of protease inhibitors in clinical practice." Paper presented at the fifth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 1998a.
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. New England Journal of Medicine 339(5):307-311, 1998b.
Heterosexism and homophobia. In: Cabaj, R.P., and Stein, T.S., eds. Textbook of Homosexuality and Mental Health: A Comprehensive Review. Washington, DC: American Psychiatric Press, 1996. pp. 101-113.
Party favors--Do yourself one: Get the dope on the protease effect. POZ June 1998. http://www.thebody.com/poz/survival/6_98/warning.html [Accessed April 15, 1999].
Evaluation of the Effects of Ryan White Title I Funding on Services for HIV-Infected Drug Abusers: Summary Report & Executive Summary for Year 1: Baseline. A joint project of the Health Resources and Services Administration, the National Institute on Drug Abuse, and the Consortium on Drug Abuse and HIV Services Access. Pub No. HRSA-RD-SP-94-8. Washington, DC: U.S. Department of Health and Human Services, 1994.
Reinforcing operants other than abstinence: An effective alternative for reducing drug use. Journal of Consulting and Clinical Psychology 65:421-428, 1997.
Subcommittee of Taxonomy. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Pain Suppl 3:S1-S226, 1986.
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--A meta-analysis of 15 prospective cohort studies. New England Journal of Medicine 340(13):977-987, 1999.
Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. International Clinical Psychopharmacology 11:109-117, 1996.
Pharmacy access to sterile syringes for injection drug users: Attitudes of participants in a syringe exchange program. Journal of the American Pharmaceutical Association 39(1):17-22, 1999.
Psychological and social factors associated with histories of risk for human immunodeficiency virus infection among African-American inner-city women. Journal of Womens Health 6(2):209-217, 1997.
The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 277:478(481, 1997.
The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and services utilization. American Journal of Orthopsychiatry 66(1):17-31, 1996.
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug abusers and persons in clinics for sexually transmitted diseases. New England Journal of Medicine 326:75-80, 1992.
Street youth in Los Angeles. Profile of a group at high risk for human immunodeficiency virus infection. Archives of Pediatrics and Adolescent Medicine 149(5):513-519, 1995.
Ethical principles and decisions in student affairs. In: Cannon, H.J., and Brown, R.D., eds. Applied Ethics in Student Services. New Directions for Student Services, No. 30. San Francisco: Jossey-Bass, 1985. pp. 17-29.
Using methadone effectively: Achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs. In: Pickens, R.W.; Leukfeld, C.G.; and Schuster, C.R., eds. Improving Drug Abuse Treatment. NIDA Research Monograph Series, Number 106. DHHS Pub. No. (ADM) 91-1754. Rockville, MD: National Institute on Drug Abuse, 1991. pp. 245-266.
Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention. American Psychologist 48:1035-1045, 1993.
International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet 352(9128):597-600, 1998.
Transitional case management: A service model for AIDS outreach projects. In: Ashery, R.S., ed. Progress and Issues in Case Management. NIDA Research Monograph Series, Number 127. DHHS Pub. No. (ADM) 92-1946. Rockville, MD: National Institute on Drug Abuse, 1992. pp. 112-144.
Analysis of HIV-1 load in blood, semen, and saliva: Evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10(14):F51-F56, 1996.
HIV prevalence among injection drug users in three Northern California communities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19(2):200, 1998.
Still working after all these years: Increasing evidence of needle exchange program (NEP) effectiveness in studies published since 1993. International Conference on AIDS 12:670 (Abstract No. 33403), 1998.
HIV/AIDS behind bars: Incarceration provides a valuable opportunity to implement HIV/AIDS treatment and prevention strategies in a high-risk population. Journal of the International Association of Physicians in AIDS Care 4(4):8(13, 1998.
Sex, drugs and HIV counseling and testing: A prospective study of behavior-change among methadone-maintenance clients in New England. AIDS 11(2):229-235, 1997.
Analysis of AIDS Prevention Among African Americans and Hispanics in the United States. National Technical Information Service Order No. PB96-10851 INZ. Washington, DC: Office of Technology Assessment, 1995.
Harm reduction: Application to alcohol abuse problems. In: Onken, L.S.; Blaine, J.D.; and Boren, J.J., eds. Behavioral Treatments for Drug Abuse and Dependence. NIDA Research Monograph Series, Number 137. DHHS Pub. No. (ADM) 93-3684. Rockville, MD: National Institute on Drug Abuse, 1993. pp. 147-166.
Psychosocial histories, social environment, and HIV risk behaviors of injection and noninjection drug using homeless youths. Journal of Psychoactive Drugs 30(1):1-9, 1998.
HIV in Prisons and Jails, 1995. Bureau of Justice Statistics. Pub. No. NCJ-164260. Washington, DC: U.S. Department of Justice, Office of Justice Programs, 1997. http://www.ojp.usdoj.gov/bjs/pub/ascii/hivpj95.txt [Accessed July 20, 1999].
A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 13:761-767, 1996.
An outbreak of community acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction. New England Journal of Medicine 305(24):1431-1438, 1981.
Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Annals of Internal Medicine 97(4):533-539, 1982.
Development and implementation of an interorganizational case management model for substance users. In: Ashery, R.S., ed. Progress and Issues in Case Management. NIDA Research Monograph Series, Number 127. DHHS Pub. No. (ADM) 92-1946. Rockville, MD: National Institute on Drug Abuse, 1992. pp. 331-349.
Case management services for HIV-seropositive IDUs. In: Ashery, R.S., ed. Progress and Issues in Case Management. NIDA Research Monograph Series, Number 127. DHHS Pub. No. (ADM) 92-1946. Rockville, MD: National Institute on Drug Abuse, 1992. pp. 181-207.
Lesbian recovering alcoholics: A qualitative study of identity transformation. A report on research and applications to treatment. Journal of Chemical Dependency Treatment 5(1):93-103, 1992.
Alcohol use and abuse among Mexican-Americans. In: Freeman, E.M., ed. Social Work Practice With Clients Who Have Alcohol Problems. Springfield, IL: Charles C. Thomas, 1985.
Primate studies of the behavioral pharmacology of buprenorphine. In: Blaine, J.D., ed. Buprenorphine: An Alternative Treatment for Opioid Dependence. NIDA Research Monograph Series, Number 121. DHHS Pub. No. (ADM) 92-1912. Rockville, MD: National Institute on Drug Abuse, 1992. pp. 61-100.
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6:1049-1056, 1993.
Behavioral treatments for drug problems: Lessons from the alcohol treatment outcome literature. In: Onken, L.S.; Blaine, J.D.; and Boren, J.J., eds. Behavioral Treatment for Drug Abuse and Dependence. NIDA Research Monograph Series, Number 137. DHHS Pub. No. (ADM) 93-3684. Rockville, MD: National Institute on Drug Abuse, 1993. pp. 167-180.
Sexually-transmitted disease in female adolescents: Effects of psychosocial factors and high risk behaviors. Journal of Adolescent Health 17(2):83-90, 1995.
Substance Abuse: Patterns and Barriers to Treatment for Gay Men and Lesbians in San Francisco. San Francisco: San Francisco Department of Public Health, 1983.
"Freedom and HIV prevention: Challenges facing Latino inmates leaving prison." Paper presented at the 103rd American Psychological Association Convention, New York, 1995.
Alcohol and other drug use in female medical students: A comparison of lesbians and heterosexuals. Journal of Gay and Lesbian Psychotherapy 2(1):37-48, 1993.
Substance Abuse and Treatment, State and Federal Prisoners, 1997. Bureau of Justice Statistics. Pub No. NCJ-172871. Washington, DC: U.S. Department of Justice, Office of Justice Programs, 1999.
Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Annals of Internal Medicine 113:872-881, 1990.
Infective endocarditis in intravenous drug users: A comparison of human immunodeficiency virus type 1-negative and -positive patients. Journal of Infectious Diseases 162(4):967-970, 1990.
"Ethical Issues, HIV/AIDS, and Social Work Practice." Workshop sponsored by the HIV/AIDS Spectrum: Mental Health Training and Education of Social Workers Project, 1997.
HIV and Adolescents. NIAID Fact Sheet. Washington, DC: National Institutes of Health, February 1999. http://www.niaid.nih.gov/factsheets/hivadolescent.htm [Accessed May 18, 1999].
HIV prevention with drug-using populations: Current status and future prospects: Introduction and overview. Public Health Reports 113(Suppl.1):4(18, 1998.
Letter to John Harkness, M.D., Oklahoma State Department of Health, from the Legal Advisor to the U.S. Alcohol, Drug Abuse, and Mental Health Administration, September 2, 1988. In: Center for Substance Abuse Treatment. Confidentiality of Patient Records for Alcohol and Other Drug Treatment. Technical Assistance Publication (TAP) Series, Number 13. DHHS Pub. No. (SMA) 95-3018. Washington, DC: U.S. Government Printing Office, 1995.
Cultural sensitivity in drug treatment research with African American males. In: Trimble, J.E.; Bolek, C.S.; and Niemrcyk, S.J., eds. Ethnic and Multicultural Drug Abuse. Binghampton, NY: The Haworth Press, 1992. pp. 157(179.
Human Immunodeficiency Virus(HIV-1) Guidelines for Chemical Dependency Treatment and Care Programs in Minnesota. St. Paul, MN: Chemical Dependency Program Division, Minnesota Department of Human Services, 1989.
Hypnotics and sedatives: Ethanol. In: Gilman, A.G.; Rall, T.W.; Nies, A.S.; and Taylor, P., eds. Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th ed. New York: Pergamon Press, 1990. pp. 345-382.
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264(19):2511-2518, 1990.
Estimating the sexual mixing patterns in the general population from those in people acquiring gonorrhoea infection: Theoretical foundation and empirical findings. Journal of Epidemiology and Community Health 49:205-213, 1995.
Motivators and Barriers to Use of Combination Therapies in Patients With HIV Disease. CAPS Monograph Series, Occasional Paper No. 5. San Francisco: University of California at San Francisco, Center for AIDS Prevention Studies, 1998.
The natural history of HIV-1 infection. In: Broder, S.; Merigan, T.C.; and Bolognesi, D., eds. Textbook of AIDS Medicine. Baltimore: Williams & Wilkins, 1994. pp. 45-53.
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Archives of Internal Medicine 155:1629-1633, 1995.
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic. American Journal of Medicine 92(5):495-502, 1992.
HIV Postexposure Prevention (PEP). Summary Sheets on HIV Treatment Strategies. Updated December 18, 1997a. http://www.sfaf.org/ treatment/factsheets/pep.html [Accessed April 19, 1999].
HIV viral load and CD4 T-cell testing, drug resistance, and adherence to HAART. Summary Sheets on HIV Treatment Strategies. Updated December 18, 1997b. http://www.sfaf.org/treatment/factsheets/viral_load.html [Accessed April 23, 1999].
Protease inhibitor drugs and new HIV treatment strategies. Summary Sheets on HIV Treatment Strategies. Updated December 18, 1997c. http://www.sfaf.org/treatment/factsheets/ index.html [Accessed April 19, 1999].
Verbal and physical abuse as stressors in the lives of lesbian, gay male, and bisexual youths: Association with school problems, running away, substance abuse, prostitution, and suicide. Journal of Consulting and Clinical Psychology 62(2):261-269, 1994.
Case management as a mechanism for linking drug abuse treatment and primary care: Preliminary evidence from the ADAMHA/HRSA linkage demonstration. In: Ashery, R.S., ed. Progress and Issues in Case Management. NIDA Research Monograph Series, Number 127. DHHS Pub. No. (ADM) 92-1946. Rockville, MD: National Institute on Drug Abuse, 1992. pp. 316-330.
A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. New England Journal of Medicine 327:1836-1841, 1992.
Pain in far advanced AIDS. In: Foley, K.M.; Bonica, J.J.; and Ventafridda, V., eds. Advances in Pain Research and Therapy. Vol. 16. Proceedings of the Second International Congress on Cancer Pain. New York: Raven Press, 1990. pp. 379-386.
Advancing the application of behavioral treatment approaches for drug dependence. In: Onken, L.S.; Blaine, J.D.; and Boren, J.J., eds. Behavioral Treatment for Drug Abuse and Dependence. NIDA Research Monograph Series, Number 137. DHHS Pub. No. (ADM) 93-3684. Rockville, MD: National Institute on Drug Abuse, 1993. pp. 5-17.
Transsexuals: The boundaries of sexual identity and gender. In: Cabaj, R.P., and Stein, T.S., eds. Textbook of Homosexuality and Mental Health. Washington, DC: American Psychiatric Press, 1996. pp. 743-762.
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. New England Journal of Medicine 327:1697-1703, 1992.
Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports 108:492-500, 1993.
Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Annals of Internal Medicine 111:761-763, 1989.
Hazardous terrain and over the edge: The survival of HIV-positive heterosexual, minority men. Journal of the Association of Nurses AIDS Care 9(4):23-34, 1998.
Moving beyond fear: Lessons learned through a longitudinal review of the literature regarding health care providers and the care of people with HIV/AIDS. Nursing Clinics of North America 34(1):1-48, 1999.
Hope and resilience in suicide ideation and behavior of gay and bisexual men following notification of HIV infection. AIDS Education and Prevention 11(1):53-64, 1999.
Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Archives of General Psychiatry 53:409-415, 1996.
Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. New England Journal of Medicine 319(5):274-278, 1988.
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implcations for enhancing compliance. AIDS Care 8:261-269, 1996.
The prevalence and demographic predictors of illicit and licit drug use among lesbians and gay men. American Journal of Public Health 84:1307-1310, 1994.
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. Journal of Hepatology 26(1):1-5, 1997.
Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: Implications for secondary prevention efforts. Journal of AIDS and Human Retroviruses 11:151-160, 1996.
Alcohol and drug use during sexual activity and compliance with safe sex guidelines for AIDS: The AIDS Behavior Research Project. Health Education Quarterly 13:359-371, 1986.
An outcome evaluation to measure changes in sexual risk-taking among gay men undergoing substance use disorder treatment. Journal of Studies on Alcohol 60(6):837-845, 1999.
A comparison of alcohol and drug use patterns of homosexual and heterosexual men: The San Francisco Men's Health Study. Drug and Alcohol Dependency 22:63-73, 1988.
The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. Annals of Internal Medicine 121(2):100-108, 1994.
"Healing the hurt: A conference on homphobia." Paper presented at the Parents, Families, and Friends of Lesbians and Gays (PFLAG) Conference, Houston, TX, 1994.
Reducing the Odds: Preventing Perinatal Transmission of HIV in the United States. Washington, DC: National Academy Press, 1998. http://www.nap.edu/readingroom/books/odds [Accessed November 12, 1998].
Correctional systems. In: Jonsen, A.R., and Stryker, J., eds. The Social Impact of AIDS in the United States. Washington, DC: National Academy Press, 1993. pp. 176-200.
Summary of Findings from the 1998 National Household Survey on Drug Abuse. DHHS Pub. No. (SMA) 99-3328. Washington, DC: Government Printing Office, 1999.
The Tuskegee Syphilis Study, 1932 to 1972: Implications for HIV education and AIDS risk education programs in the black community. American Journal of Public Health 81(11):1498-1505, 1991.
Report of the Tuskegee Syphilis Study Legacy Committee: Final Report. May 20, 1996. http://www.med.virginia.edu/hs-library/historical/apology/report.html. [Accessed December 22, 1999].
Resident Population of the United States: Estimates, by Sex, Race, and Hispanic Origin, With Median Age. December 28, 1998. http://www.census.gov/ population/estimates/nation/intfile3-1.txt [Accessed May 10, 1999].
Needle Exchange Programs: Part of a Comprehensive HIV Prevention Strategy. Fact Sheet. April 20, 1998. http://waisgate.hhs. gov/news/press/1998pres/980420a.html [Accessed December 6, 1999].
Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, 1997. http://hivpositive.com/f-treatment/NIH_Guidelines/NIHguideMenu.html [Accessed December 11, 1998].
Drug Treatment: Despite New Strategy, Few Federal Inmates Receive Treatment. Report to the Committee on Government Operations, House of Representatives. GAO/HRD-91-128. Washington, DC: U.S. Government Printing Office, 1991.
Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy. Report to the Chairman, Select Committee on Narcotics Abuse and Control. GAO/HRD-93-60. Washington, DC: U.S. Government Printing Office, 1993.
Drug Abuse: Research Shows Treatment Is Effective, But Benefits May Be Overstated. GAO/HEHS-98-72. Washington, DC: U.S. Government Printing Office, 1998.
Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Journal of Drug and Alcohol Dependence 37(3):261-269, 1995.
AIDS prevention for intravenous drug users in the community: Street-based education and risk behavior. American Journal of Community Psychology 18:587-596, 1990.
Women living with substance abuse and HIV disease: Medical care access issues. Journal of the American Medical Women's Association 50(3-4):115(120, 1995.
Women living with drug abuse and HIV disease: Drug abuse treatment access and secondary prevention issues. Journal of Psychoactive Drugs 27(4):401(411, 1995.
HIV risk assessment and prevention in lesbians and women who have sex with women: Practical information for clinicians. Health Care for Women International 18(2):127-138, 1997.
Outreach to IDUs not in treatment. In: Brown, B.S., and Beschner, G.M., eds. Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood Press, 1993. pp. 437-444.
"High HIV prevalence among female and male entrants to U.S. correctional facilities (1989-1992): Implications for prevention and treatment strategies." Paper presented at the 121st Annual Meeting of the American Public Health Association, San Francisco, CA, October 24-28, 1993.
HIV and Infant Feeding: A Review of HIV Transmission Through Breastfeeding. Joint United Nations Programme on HIV/AIDS (UNAIDS), 1998. http://www.unaids.org/publications/ documents/mtct/index.html [Accessed August 31, 1999].
Frequency of transmission of drug-resistant variants in individuals with primary HIV-1 infection (Abstract No. 32280). 12th World AIDS Conference, Geneva, Switzerland, 1998.
Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: A double-blind, placebo-controlled study. European-Australian Acyclovir Study Group. AIDS 8(5):641-649, 1994.
Letter to Peter J. Millock, General Counsel, Department of Health, State of New York, from the Acting General Counsel to the U.S. Department of Health and Human Services, May 17, 1989. In: Center for Substance Abuse Treatment. Confidentiality of Patient Records for Alcohol and Other Drug Treatment. Technical Assistance Publication (TAP) Series, Number 13. DHHS Pub. No. (SMA) 95-3018. Washington, DC: U.S. Government Printing Office, 1995.